Korea Institute of Radiological & Medical Sciences

Kolon Industries, Inc.

Fnct Biotech, Inc

Hae June Lee

Min Jung Kim

Seung Woo Park

Jong Hyun Back

A Ram Kim

Mun Sik Choi

Su Chul Han

Yoon Jin Lee

Chung Suk Kang

Su Jae Lee

Il Young Kim

Mi Young Choi

Jae Kyung Myung

Jae Kyung Nam

Kyeng Jung Kim

Chang B Jung

Suh H Cho

Il Y Jung

Chang G Kim

A new use of M-CSF or G-CSF as a useful marker for diagnosis or treatment of pulmonary fibrosis is disclosed. Also disclose are a composition containing M-CSF inhibitor and/or G-CSF inhibitor, as active ingredients, wherein the composition is suitable for preventing or treating pulmonary fibrosis. A composition containing M-CSF inhibitor and/or G-CSF inhibitor which bind to M-CSF and G-CSF, respectively, has an effect of significantly inhibiting myofibroblast hyperplasia or pulmonary fibrosis of the pulmonary cells.

Use of G-CSF antibody for treatment of pulmonary fibrosis

A radiotherapy apparatus for an animal comprises a treatment part including an accommodation space for placing an animal, an irradiation part including an electron generator and a linear accelerator coupled to one side of the electron generator and disposed in a direction perpendicular to the treatment part, the linear accelerator being configured to emit radiation toward the treatment part, and an image acquisition part located at a preset interval from the treatment part along an irradiation direction of the radiation and configured to obtain an image of an irradiation area when the radiation is applied, wherein the radiation has an output of 1 MeV to 2 MeV so as to be applied to a diseased part located within a predetermined distance range from epidermis of the animal.

Radiotherapy apparatus for animal

The present invention relates to a pharmaceutical composition for radioprotection or radiomitigation with respect to radiation-induced damage, the composition comprising a compound of Formula 1, or a pharmaceutically acceptable salt thereof or a solvate thereof.

Pharmaceutical compositions for radioprotection or radiomitigation and methods for using them

A method for fabricating olefin tarpaulins by treating both sides of a base fabric woven from high strength polyester filaments with a coating composition using an extruder followed by compressing the coated polyester fabrics with a calendering roller. The coating composition is obtained by dry-blending or melt-blending LLDPE (linear low density polyethylene) or LDPE (low density polyethylene) in an amount of 15.about.94.5% by weight with an elastomer of ethylene-.alpha.-olefin co-polymer of 5.about.60% by weight which are (i) ethylene propylene rubbers or (ii) co-polymers of ethylene and octene or butene; coloring master batch chip in an amount of 0.5.about.15% by weight obtained by mixing LLDPE or LDPE with pigments or titanium dioxide; and adhesion-preventing master batch chip of 0.about.10% by weight obtained by mixing LLDPE or LDPE with silica or calcium carbonate.

Method for fabricating olefin tarpaulins

Growing community of inventors

Seoul, South Korea

Hae June Lee